Dudediligence.

Lisata Therapeutics, Inc

LSTANASDAQ · Pharmaceutical Preparations
Write an idea

Price
FilingsNewest: 8-K, Material agreementSep 17 →InsidersNo open-market buys or sales.→HoldersVanguard 3.1%Yakira 1.5%CSS Llc/il 1.2%→Financing →PeersClosest companies: NMTC, JSPR, CNSP→

From the filings

Figures

Revenue
$100,000last 12 months
Net income
−$14.6Mlast 12 months
Operating cash flow
−$13.6Mlast 12 months
Cash and equivalents
$10.4Mat the last balance sheet
Shares outstanding
9.1M shareson issue
Every year and quarter →